HK$21.18
0.00%
Hong Kong, Sep 21, 09:30 am HKT.
ISIN
CNE100004QP1
Symbol
2252

Shanghai Microport Medbot-h Target price 2026 - Analyst rating & recommendation

Shanghai Microport Medbot-h Classifications & Recommendation

Buy
87%
Hold
13%

Shanghai Microport Medbot-h Price Target

Target Price HK$40.68
Price HK$21.18
Potential
Number of Estimates 10
10 Analysts have issued a price target Shanghai Microport Medbot-h 2027 . The average Shanghai Microport Medbot-h target price is HK$40.68. This is higher than the current stock price. The highest price target is
HK$43.05 103.26%
register free of charge
, the lowest is .
A rating was issued by 15 analysts: 13 Analysts recommend Shanghai Microport Medbot-h to buy, 2 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Shanghai Microport Medbot-h stock has an average upside potential 2027 of . Most analysts recommend the Shanghai Microport Medbot-h stock at Purchase.

Sales and Margin forecast 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Revenue Million HK$ 645.66 1,398.95
114.21% 116.67%
EBITDA Margin -11.26% 18.14%
91.88% 261.17%
Net Margin -45.30% 8.03%
81.86% 117.72%

10 Analysts have issued a sales forecast Shanghai Microport Medbot-h 2026 . The average Shanghai Microport Medbot-h sales estimate is

HK$1.4b
unlock
. This is
116.67% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HK$1.7b 157.86%
unlock
, the lowest is
HK$1.1b 71.61%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 HK$646m 114.21%
2026
HK$1.4b 116.67%
unlock
2027
HK$2.1b 52.60%
unlock
2028
HK$3.0b 42.10%
unlock

10 Shanghai Microport Medbot-h Analysts have issued a net profit forecast 2026. The average Shanghai Microport Medbot-h net profit estimate is

HK$112m
unlock
. This is
138.40% higher
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HK$330m 212.78%
unlock
, the lowest is
HK$-71.1m 75.71%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 HK$-293m 61.14%
2026
HK$112m 138.40%
unlock
2027
HK$418m 272.47%
unlock
2028
HK$707m 69.11%
unlock

Net Margin

2025 -45.30% 81.86%
2026
8.03% 117.72%
unlock
2027
19.60% 144.08%
unlock
2028
23.32% 18.98%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 & 2028

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Dec '25 2026
Estimates
Earnings Per Share HK$ -0.29 0.11
62.82% 137.93%
P/E 194.48
EV/Sales 15.52

10 Analysts have issued a Shanghai Microport Medbot-h forecast for earnings per share. The average Shanghai Microport Medbot-h EPS is

HK$0.11
unlock
. This is
137.93% higher
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
HK$0.32 210.34%
unlock
, the lowest is
HK$-0.07 75.86%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 HK$-0.29 62.82%
2026
HK$0.11 137.93%
unlock
2027
HK$0.41 272.73%
unlock
2028
HK$0.69 68.29%
unlock

P/E ratio

Current -73.03 43.10%
2026
194.48 366.29%
unlock
2027
52.21 73.15%
unlock
2028
30.88 40.85%
unlock

Based on analysts' sales estimates for 2026, the Shanghai Microport Medbot-h stock is valued at an EV/Sales of

15.52
unlock
and an P/S ratio of
15.70
unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 33.62
2026
15.52 53.85%
unlock
2027
10.17 34.47%
unlock
2028
7.16 29.63%
unlock

P/S ratio

Current
2026
15.70 53.85%
unlock
2027
10.29 34.47%
unlock
2028
7.24 29.63%
unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today